This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
The Norwegian ParkWest study is a prospective population-based longitudinal cohort study of patients with incident Parkinson’s Disease in Western and Southern Norway, with a total base population of more than 1 million inhabitants. The initial cohort comprised of 212 newly-diagnosed and drug-naïve individuals with suspected Parkinson’s disease, who were followed with standardized clinical examinations every 6 months. More comprehensive assessments, including neuropsychological and behavioural evaluations, were conducted at baseline and 1-year of follow-up, and at 2-year intervals thereafter. Currently, study participants are in the 10th year of follow-up. About 110 patients are still in the study.
Last update – 10/04/2017
Types Neurodegenerative disease-specific cohort
Participant Types Condition diagnosed
Countries Norway
Genders Male and Female
Sample sizes 0 to 4,999
Ages 10 to 19|20 to 39|40 to 59|60 to 100
Brain related measures Behaviour|Cognitive function|Mental health|Neurological
Funtional rating Caregiver|Individual physiological|Individual psychological
Anthropometric Height|Weight
Physical
Biological samples Blood|Cerebral spinal fluid (CSF)
Genotyping Gene screening
Brain imaging Magnetic resonance imaging (MRI)
Brain banking Consent for brain donation
Lifestyle Alcohol|Smoking
Socio-economic Education|Ethnic group|Family circumstances|Housing and accommodation|Marital status|Occupation and employment|Unpaid care
Health service utilisation
Institute names Stavanger University Hospital
Current Sample Sizes 0 to 4,999
age at recruitment >18
last updated
recruitment period 2004-2006
estimated current sample size number value 110
cohort acronym ParkWest
start date 2004-2006
pi Professor Guido Alves|Professor Ole-Bjorn Tysnes
website http://www.parkvest.no/
contact details The Norwegian Centre for Movement Disorders
Stavanger University Hospital
PO Box 8100
4068 Stavanger
Norway
abstract ParkWest is a prospective cohort study of patients with incidents of PD in Norway. 212 participants over 18 years of age were recruited between 2004 and 2006.
funders Norwegian Parkinson Research Foundation
Western Norway Regional Health Authority
Research Council of Norway
contact email Email: [email protected]|[email protected]| PI Email: [email protected]
contact phone number +47 51 51 52 18
estimated current sample size 0 to 4,999
sample sizes 212
